Product Information

EZETIMIBE 10 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0704 per EA under NDC 00904710310. Its NADAC has been published 156 times since Nov 22, 2023.

FDA first approved this application on Dec 21, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EZETIMIBE 10 MG TABLET

Ezetimibe
$0.0704per EA

Strength

10 mg/1

NDC

00904710310

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

EZETIMIBE

Approval Type

Generic (ANDA)

FDA Application

ANDA209234

FDA Approved

12/21/2017

TE Code

AB

On Market Since

12/23/2017

Pharmacological Classes

Decreased Cholesterol Absorption
Dietary Cholesterol Absorption Inhibitor

Price Statistics

The NADAC for EZETIMIBE 10 MG TABLET has been published 156 times since Nov 22, 2023, and over the history we have for it it has declined 18.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0704 per EA
All-time high$0.1021 (Apr 10, 2024)
All-time low$0.0667 (Sep 23, 2026)
52-week high$0.0756
52-week low$0.0667
Median price$0.0753
Average price$0.0770
Largest weekly change+22.7% (Jun 19, 2024)
Weeks tracked156
Tracking sinceNov 22, 2023

Price History

1W

0.0%

1M

+5.6%

3M

+4.9%

6M

-2.7%

1Y

+2.5%

3Y

N/A

5Y

N/A

All

-18.3%

Generic Alternatives

The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EZETIMIBE 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE 10 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0704 per EA (NDC 00904710310), effective Nov 11, 2026.

How has the price of EZETIMIBE 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for EZETIMIBE 10 MG TABLET has declined 18.3%. It has been tracked across 156 weekly CMS publications since Nov 22, 2023.

What are the highest and lowest recorded NADAC prices for EZETIMIBE 10 MG TABLET?

Since Nov 22, 2023, the NADAC for EZETIMIBE 10 MG TABLET has ranged from a low of $0.0667 (Sep 23, 2026) to a high of $0.1021 (Apr 10, 2024), with a median of $0.0753 per EA.

Are there cheaper alternatives to EZETIMIBE 10 MG TABLET?

Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE 10 MG TABLET, is $0.0672 per EA — about 5% below EZETIMIBE 10 MG TABLET.

Who manufactures EZETIMIBE 10 MG TABLET?

EZETIMIBE 10 MG TABLET (NDC 00904710310) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.